290 related articles for article (PubMed ID: 15908747)
1. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
[TBL] [Abstract][Full Text] [Related]
2. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
3. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
4. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
[TBL] [Abstract][Full Text] [Related]
5. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
[TBL] [Abstract][Full Text] [Related]
6. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
[TBL] [Abstract][Full Text] [Related]
7. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease.
Nagao M; Sugawara Y; Ikeda M; Fukuhara R; Hokoishi K; Murase K; Mochizuki T; Miki H; Kikuchi T
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):162-8. PubMed ID: 15129697
[TBL] [Abstract][Full Text] [Related]
9. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
10. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
11. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
[TBL] [Abstract][Full Text] [Related]
12. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
[TBL] [Abstract][Full Text] [Related]
14. [Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias].
Gerasimou G; Bostantjopoulou S; Gotzamani-Psarrakou A
Hell J Nucl Med; 2009; 12(1):79-83. PubMed ID: 19330195
[TBL] [Abstract][Full Text] [Related]
15. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
16. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
[TBL] [Abstract][Full Text] [Related]
17. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of 18F-FDG PET and ictal 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPET.
Lee JJ; Kang WJ; Lee DS; Lee JS; Hwang H; Kim KJ; Hwang YS; Chung JK; Lee MC
Seizure; 2005 Apr; 14(3):213-20. PubMed ID: 15797357
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging in dementia.
Herholz K; Carter SF; Jones M
Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
[TBL] [Abstract][Full Text] [Related]
20. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
